Atlas Trials

Study of the Effect of Vedolizumab on Intestinal Microecological Changes and Its Efficacy in the Treatment of Ulcerative Colitis

Clinical trial NCT05481619 · RECRUITING

Trial details

NCT number
NCT05481619
Sponsor
Second Affiliated Hospital, Zhejiang University, School of Medicine
Status
RECRUITING
Phase
Phase 4
Study type
INTERVENTIONAL
Ulcerative Colitis
Start date
2021-01-01
Primary completion
2026-01-01
Enrollment
30

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.